abstract |
The present invention relates to novel pharmaceutically acceptable salts of 7-[(3R)-3- amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-[1,2,-4]-triazolo [4,3-a]pyrazine of Formula (I), or solvates or hydrates thereof. |